A citation-based method for searching scientific literature

Hae-Yun Jung, Xin Wang, Sohee Jun, Jae-Il Park. J Biol Chem 2013
Times Cited: 45







List of co-cited articles
258 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
Naoe Taira, Keishi Nihira, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. Mol Cell 2007
210
37

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.
Naoe Taira, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Yoshio Miki, Kiyotsugu Yoshida. J Clin Invest 2012
94
37

DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Rei Mimoto, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe, Ken Uchida, Yoshio Miki, Kiyotsugu Yoshida. Cancer Lett 2013
53
33

DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer.
Shin-ichi Yamashita, Masao Chujo, Toshihiko Moroga, Kentaro Anami, Keita Tokuishi, Michiyo Miyawaki, Yozo Kawano, Shinsuke Takeno, Satoshi Yamamoto, Katsunobu Kawahara. Anticancer Res 2009
27
44

Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Xiubing Zhang, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang, Shumin Lu, Li Liang, Jinxia Liu,[...]. Pathol Res Pract 2016
24
41

ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.
Naoe Taira, Hiroyuki Yamamoto, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. J Biol Chem 2010
51
20

Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer.
Yasuko Enomoto, Shin-ichi Yamashita, Yasuteru Yoshinaga, Yasuyoshi Fukami, So Miyahara, Kazuki Nabeshima, Akinori Iwasaki. Tumour Biol 2014
23
39

HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.
Xin Wang, Shailbala Singh, Hae-Yun Jung, Guojun Yang, Sohee Jun, K Jagannadha Sastry, Jae-Il Park. J Biol Chem 2013
28
28

Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response.
Yoshiomi Honda, Masahide Tojo, Kazuhito Matsuzaki, Tadashi Anan, Mitsuhiro Matsumoto, Masayuki Ando, Hideyuki Saya, Mitsuyoshi Nakao. J Biol Chem 2002
90
17

Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1VprBP.
Delowar Hossain, Yalda Javadi Esfehani, Arindam Das, William Y Tsang. EMBO Rep 2017
29
27

Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Moisés Pérez, Carmen García-Limones, Inés Zapico, Anabel Marina, M Lienhard Schmitz, Eduardo Muñoz, Marco A Calzado. J Mol Cell Biol 2012
44
15

Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
Pamela A Lochhead, Gary Sibbet, Nick Morrice, Vaughn Cleghon. Cell 2005
214
15

Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
Shunichiro Nomura, Yasutomo Suzuki, Ryo Takahashi, Mika Terasaki, Ryoji Kimata, Yasuhiro Terasaki, Tsutomu Hamasaki, Go Kimura, Akira Shimizu, Yukihiro Kondo. BMC Urol 2015
17
41


DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
Noriko Yamaguchi, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto, Kiyotsugu Yoshida. Tumour Biol 2015
28
25

Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
R Mimoto, Y Imawari, S Hirooka, H Takeyama, K Yoshida. Oncogene 2017
22
31

Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
Shiho Yokoyama-Mashima, Satomi Yogosawa, Yumi Kanegae, Shinichi Hirooka, Saishu Yoshida, Takashi Horiuchi, Toya Ohashi, Katsuhiko Yanaga, Masayuki Saruta, Tsunekazu Oikawa,[...]. Cancer Lett 2019
16
43

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Haiyan Yan, Kaishun Hu, Wenjing Wu, Yu Li, Huan Tian, Zhonghua Chu, H Phillip Koeffler, Dong Yin. PLoS One 2016
20
35

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Charles T Miller, Sanjeev Aggarwal, Theodore K Lin, Susan L Dagenais, Jorge I Contreras, Mark B Orringer, Thomas W Glover, David G Beer, Lin Lin. Cancer Res 2003
46
13


Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Shin-ichi Yamashita, Masao Chujo, Keita Tokuishi, Kentaro Anami, Michiyo Miyawaki, Satoshi Yamamoto, Katsunobu Kawahara. J Thorac Cardiovasc Surg 2009
12
50

Engagement of DYRK2 in proper control for cell division.
Naoe Taira Nihira, Kiyotsugu Yoshida. Cell Cycle 2015
27
22

Regulation of Glioma Cells Migration by DYRK2.
Yifen Shen, Li Zhang, Donglin Wang, Yifeng Bao, Chao Liu, Zhiwei Xu, Wei Huang, Chun Cheng. Neurochem Res 2017
10
60

Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.
Xing Guo, Xiaorong Wang, Zhiping Wang, Sourav Banerjee, Jing Yang, Lan Huang, Jack E Dixon. Nat Cell Biol 2016
104
13

Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
Meera Soundararajan, Annette K Roos, Pavel Savitsky, Panagis Filippakopoulos, Arminja N Kettenbach, Jesper V Olsen, Scott A Gerber, Jeyanthy Eswaran, Stefan Knapp, Jonathan M Elkins. Structure 2013
97
13

Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Daisuke Ito, Satomi Yogosawa, Rei Mimoto, Shinichi Hirooka, Takashi Horiuchi, Ken Eto, Katsuhiko Yanaga, Kiyotsugu Yoshida. Cancer Sci 2017
20
30

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
Erwann Le Rouzic, Nadia Belaïdouni, Emilie Estrabaud, Marina Morel, Jean-Christophe Rain, Catherine Transy, Florence Margottin-Goguet. Cell Cycle 2007
208
11

Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
466
11

DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.
Yizhou Joseph He, Chad M McCall, Jian Hu, Yaxue Zeng, Yue Xiong. Genes Dev 2006
266
11


EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response.
Michelle J Henderson, Amanda J Russell, Samantha Hird, Marcia Muñoz, Jennifer L Clancy, Gillian M Lehrbach, Sophina T Calanni, David A Jans, Robert L Sutherland, Colin K W Watts. J Biol Chem 2002
85
11

Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling.
Markku Varjosalo, Mikael Björklund, Fang Cheng, Heidi Syvänen, Teemu Kivioja, Sami Kilpinen, Zairen Sun, Olli Kallioniemi, Hendrik G Stunnenberg, Wei-Wu He,[...]. Cell 2008
139
11

A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.
Yousang Gwack, Sonia Sharma, Julie Nardone, Bogdan Tanasa, Alina Iuga, Sonal Srikanth, Heidi Okamura, Diana Bolton, Stefan Feske, Patrick G Hogan,[...]. Nature 2006
288
11

Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2.
Su Sien Ong, Asli N Goktug, Ayesha Elias, Jing Wu, Darren Saunders, Taosheng Chen. Biochem J 2014
29
17


Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.
Sourav Banerjee, Chenggong Ji, Joshua E Mayfield, Apollina Goel, Junyu Xiao, Jack E Dixon, Xing Guo. Proc Natl Acad Sci U S A 2018
70
11

Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Sourav Banerjee, Tiantian Wei, Jue Wang, Jenna J Lee, Haydee L Gutierrez, Owen Chapman, Sandra E Wiley, Joshua E Mayfield, Vasudha Tandon, Edwin F Juarez,[...]. Proc Natl Acad Sci U S A 2019
24
20

Multiple functions of DYRK2 in cancer and tissue development.
Saishu Yoshida, Kiyotsugu Yoshida. FEBS Lett 2019
20
25

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
Tomotaka Kumamoto, Kohji Yamada, Saishu Yoshida, Katsuhiko Aoki, Shinichi Hirooka, Ken Eto, Katsuhiko Yanaga, Kiyotsugu Yoshida. Int J Oncol 2020
10
50

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.
Kasia Hrecka, Caili Hao, Magda Gierszewska, Selene K Swanson, Malgorzata Kesik-Brodacka, Smita Srivastava, Laurence Florens, Michael P Washburn, Jacek Skowronski. Nature 2011
883
8

EDD inhibits ATM-mediated phosphorylation of p53.
Shiyun Ling, Weei-Chin Lin. J Biol Chem 2011
34
11

Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
Kasia Hrecka, Magdalena Gierszewska, Smita Srivastava, Lukasz Kozaczkiewicz, Selene K Swanson, Laurence Florens, Michael P Washburn, Jacek Skowronski. Proc Natl Acad Sci U S A 2007
186
8

CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation.
Leigh Ann Higa, Min Wu, Tao Ye, Ryuji Kobayashi, Hong Sun, Hui Zhang. Nat Cell Biol 2006
327
8

PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.
Hae-Yun Jung, Sohee Jun, Moonsup Lee, Han-Cheon Kim, Xin Wang, Hong Ji, Pierre D McCrea, Jae-Il Park. Mol Cell 2013
126
8

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.
Yasushi Ogawa, Yosuke Nonaka, Toshiyasu Goto, Eriko Ohnishi, Toshiyuki Hiramatsu, Isao Kii, Miyo Yoshida, Teikichi Ikura, Hiroshi Onogi, Hiroshi Shibuya,[...]. Nat Commun 2010
178
8

Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs.
M J Callaghan, A J Russell, E Woollatt, G R Sutherland, R L Sutherland, C K Watts. Oncogene 1998
95
8

Poly(A) binding protein (PABP) homeostasis is mediated by the stability of its inhibitor, Paip2.
Madoka Yoshida, Kaori Yoshida, Guennadi Kozlov, Nadia S Lim, Gregory De Crescenzo, Zhiyu Pang, Juan Jose Berlanga, Avak Kahvejian, Kalle Gehring, Simon S Wing,[...]. EMBO J 2006
84
8

Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells.
Sascha Rutz, Nobuhiko Kayagaki, Qui T Phung, Celine Eidenschenk, Rajkumar Noubade, Xiaoting Wang, Justin Lesch, Rongze Lu, Kim Newton, Oscar W Huang,[...]. Nature 2015
81
8

Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Yuchan Wang, Yaxun Wu, Xiaobing Miao, Xinghua Zhu, Xianjing Miao, Yunhua He, Fei Zhong, Linlin Ding, Jing Liu, Jie Tang,[...]. Int J Biol Macromol 2015
12
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.